Evidence Hub

Clinical observation of Levofloxacin Capsules combined with Longqing Tablets in treatment of type 2 diabetes mellitus with urinary tract infection

LI Dong-y

Xiandai yaowu yu linchuang, 2014

Abstract

Objective To observe the efficacy and safety of Levofloxacin Capsules combined with Longqing Tablets in the treatment of type 2 diabetes mellitus with urinary tract infection. Methods The patients(209 cases) diagnosed with type 2 diabetes mellitus with urinary tract infection in the People's Hospital of Pingyi County from October 2012 to October 2013 were randomly divided into treatment(105 cases) and control(104 cases) groups. All the patients were given different oral medications and/or insulin according to their condition to control blood sugar, and the treatment was regulated according to the changes of blood sugar. The patients in the control group were po administered with Levofloxacin Capsules, once 2 capsules, twice daily. The patients in the treatment group were po administered with Longqing Tablets, once 6 pieces, twice daily, and other treatment was the same as the control group. Two groups were treated for 7 d. Clinical symptoms, routine urine changes, and adverse reactions were observed before and after the treatment. Results The efficiency for the patients in both the treatment and control groups was 95.2% and 76.9% with the significant difference(P 0.05). The white and red blood cells in urine decreased significantly compared with those before the treatment, and the treatment group decreased significantly compared with the control group(P 0.05). Upset stomach was the most frequent adverse reaction, and there was no significant difference between two groups.…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free